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Background:  Reduced stroke volume index (SVI) in patients with severe aortic stenosis (AS) and preserved ejection fraction (EF) is 
associated adverse outcomes even after aortic valve replacement (AVR), although specific reasons for impaired survival in this group are 
unknown. We investigated predictors of post- AVR survival and specific cause of death in patients with AS according to SVI.
methods and results:  Among 1,704 consecutive patients with severe AS (aortic valve area (AVA) <1.0 cm2) and preserved EF (≥50%) 
using 2-D and Doppler echocardiography, 103 (6%) patients had reduced SVI (<35 ml/m2 (LF) and 1601 (94%) had normal SVI (≥35 ml/m2 
(NF)). Post-AVR survival in the overall group was favorable (3 year estimate 86% (95% CI 84.6-87.4%), with low cardiac mortality (3 year 
estimate 6% (95% CI 5.1-6.9%)). Survival post-AVR was lower in patients with LF compared to NF (3 year survival in LF group 76% (95% 
CI 70-82) vs. 89% (95% CI 88-90%), p = 0.03) primarily due to higher cardiac mortality (3 year event rate 13% (95% CI 8-18%) in LF vs. 
5% (95% CI 5-7%) in NF, p=0.02). Congestive heart failure (CHF) was the most common cause of cardiac death following AVR in the LF 
group (57% of post-AVR cardiac deaths). Risk of CHF-related death after AVR was higher in LF compared to NF (3 year risk 7% vs. 2%, p 
= 0.008). Multivariable predictors of post-AVR mortality included age, serum creatinine, hemoglobin, right ventricular systolic pressure, SVI, 
and history of dementia or cognitive impairment.
conclusion:  Reduced SVI in patients with severe AS is associated with higher cardiac and non-cardiac mortality after AVR. CHF is the 
predominant cause of cardiac mortality after AVR in patients with LF, suggesting the presence of persistent myocardial impairment after 
AVR in this population. Co-morbidities including age, renal function, SVI, pulmonary hypertension, and cognitive impairment are the 
strongest predictors of survival following AVR in patients with AS.
